1. Home
  2. SKYT vs COLL Comparison

SKYT vs COLL Comparison

Compare SKYT & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWater Technology Inc.

SKYT

SkyWater Technology Inc.

N/A

Current Price

$27.74

Market Cap

1.4B

Sector

Technology

ML Signal

N/A

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

N/A

Current Price

$35.03

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SKYT
COLL
Founded
1991
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
SKYT
COLL
Price
$27.74
$35.03
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$26.50
$50.83
AVG Volume (30 Days)
872.7K
397.6K
Earning Date
05-26-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
1842.86
N/A
EPS
2.44
1.73
Revenue
$442,139,000.00
$780,567,000.00
Revenue This Year
$40.53
$6.07
Revenue Next Year
$4.01
N/A
P/E Ratio
$10.74
$20.59
Revenue Growth
29.18
23.62
52 Week Low
$5.67
$23.23
52 Week High
$36.07
$50.79

Technical Indicators

Market Signals
Indicator
SKYT
COLL
Relative Strength Index (RSI) 41.80 17.48
Support Level $14.54 $34.30
Resistance Level $31.19 $36.20
Average True Range (ATR) 1.06 1.61
MACD -0.23 -0.74
Stochastic Oscillator 1.49 7.13

Price Performance

Historical Comparison
SKYT
COLL

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: